Company: HSDTW
Filing Date: 2025-03-25
Form Type: DEF 14A
Source: 0001558370-25-003622
Chunk: 17

Company: Solana Co
Filing Date: 2025-03-25
Form: DEF 14A
Chunk 17
---
 following:

| ● | evaluating the performance of and assessing the qualifications of the independent auditors; |

| ● | determining and approving the engagement of the independent auditors; |

| ● | determining whether to retain or terminate the existing independent auditors or to appoint and engage new independent auditors; |

| ● | reviewing and approving the retention of the independent auditors to perform any proposed permissible non-audit services; |

| ● | monitoring the rotation of partners of the independent auditors on the Company’s audit engagement team as required by law; |

| ● | reviewing and approving or rejecting transactions between the Company and any related persons; |

| ● | conferring with management and the independent auditors regarding the scope, adequacy and effectiveness of internal control over financial reporting; |

| ● | establishing procedures, as required under applicable law, for the receipt, retention and treatment of complaints received by the Company regarding accounting, internal controls or auditing matters and the confidential and anonymous submission by employees of concerns regarding questionable accounting or auditing matters; and |

| ● | meeting to review the Company’s annual audited financial statements and quarterly financial statements with management and the independent auditor. |

The Audit Committee met five times during 2024. The Board has adopted a written Audit Committee charter that is available to stockholders on the Company’s website at www.heliusmedical.com.

9

The Board reviews the definition of independence for Audit Committee members under SEC rules and Nasdaq listing standards on an annual basis and has determined that all members of the Company’s Audit Committee are independent for such purposes. Report of the Audit Committee of the Board of Directors The Audit Committee has reviewed and discussed the audited financial statements for the fiscal year ended December 31, 2024 with management of the Company. The Audit Committee has discussed with the independent registered public accounting firm the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (“ PCAOB”) and the SEC. The Audit Committee has also received the written disclosures and the letter from the independent registered public accounting firm required by applicable requirements of the PCAOB regarding the independent accountants’ communications with the Audit Committee concerning independence and has discussed with the independent registered public accounting firm, the accounting firm’s independence. Based on the foregoing, the Audit Committee recommended to the Board of Directors that the audited financial statements be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Paul Buckman Edward M. Straw Blane Walter The material in this report is